Mexico
Diabetes country report 2000 — 2050
Skip Map
Number of adults (20–79 years) with diabetes in Mexico (MX)
| 2000 | 4.4 million |
| 2011 | 10.3 million |
| 2024 | 13.6 million |
| 2050 | 19.9 million |
Mexico is one of the 22 countries and territories in the IDF North America and Caribbean Region. At the time of analysing the data for this edition, Mexico was included in the country listing for the IDF NAC Region. The country will be listed among the countries in the IDF South and Central America Region for future editions. Mexico is in the top ten countries with the highest number of adults (20-79 years) with diabetes in the world.
Data source(s) used for the diabetes estimates in adults:
- Ana Cristina Basto-Abreu et al. Salud Publica Mex. 2021 Nov 5;63(6, Nov-Dic):725-733. doi: 10.21149/12842. PMID:35099912
2000
2011
2024
2050
Loading...
| Diabetes estimates (20-79 y) | ||||
|---|---|---|---|---|
| People with diabetes, in 1,000s | 4,387.3 | 10,293.7 | 13,587.4 | 19,946.9 |
| Age-standardised prevalence of diabetes, % | 14.2 | 15.6 | 16.4 | 18.0 |
| Proportion of people with undiagnosed diabetes, % | - | - | 41.3 | - |
| People with undiagnosed diabetes, in 1,000s | - | - | 5,617.9 | - |
| Impaired Fasting Glucose (IFG) | ||||
|---|---|---|---|---|
| People with IFG, in 1,000s | - | - | 11,340.1 | 15,480.6 |
| Age-standardised prevalence of IFG, % | - | - | 13.5 | 14.3 |
| Impaired Glucose Tolerance (IGT) | ||||
|---|---|---|---|---|
| People with IGT, in 1,000s | - | 7,071.9 | 10,692.3 | 15,225.7 |
| Age-standardised prevalence of IGT, % | - | 10.6 | 12.9 | 14.0 |
| Mortality attributable to diabetes (20-79 y) | ||||
|---|---|---|---|---|
| Deaths attributable to diabetes | - | 71,087.0 | 123,364.6 | - |
| Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 22.8 | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
|---|---|---|---|---|
| Live births affected by HIP | - | - | 282,930.8 | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - | - | 12.3 | - |
| Live births affected by other types of diabetes first detected in pregnancy | - | - | 32,975.6 | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - | - | 46,777.7 | - |
| Diabetes-related health expenditure | ||||
|---|---|---|---|---|
| Total diabetes-related health expenditure, USD million | - | - | 19,539.1 | 23,540.0 |
| Total diabetes-related health expenditure, ID million | - | - | 40,083.6 | 48,291.5 |
| Diabetes-related health expenditure per person, USD | - | 815.0 | 1,438.0 | 1,180.1 |
| Diabetes-related health expenditure per person, ID | - | - | 2,950.1 | 2,421.0 |
| Type 1 diabetes estimates in children and adolescents | ||||
|---|---|---|---|---|
| People with type 1 diabetes (all age groups) | - | - | 122,731.0 | - |
| People with type 1 diabetes (0-19 y) | - | - | 15,747.2 | - |
| Demographics | ||||
|---|---|---|---|---|
| Total adult population (20-79 y), in 1,000s | 55,174.0 | 69,324.0 | 85,855.3 | 104,193.1 |
| Population of children and adolescents (0-19 y) | - | - | 43,219,195.0 | - |
Loading...
| Diabetes estimates (20-79 y) | |
|---|---|
| People with diabetes, in 1,000s | 4,387.3 |
| Age-standardised prevalence of diabetes, % | 14.2 |
| Proportion of people with undiagnosed diabetes, % | - |
| People with undiagnosed diabetes, in 1,000s | - |
| Impaired Fasting Glucose (IFG) | |
|---|---|
| People with IFG, in 1,000s | - |
| Age-standardised prevalence of IFG, % | - |
| Impaired Glucose Tolerance (IGT) | |
|---|---|
| People with IGT, in 1,000s | - |
| Age-standardised prevalence of IGT, % | - |
| Mortality attributable to diabetes (20-79 y) | |
|---|---|
| Deaths attributable to diabetes | - |
| Proportion of diabetes-related deaths in people 20-79 y, % | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
|---|---|
| Live births affected by HIP | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - |
| Live births affected by other types of diabetes first detected in pregnancy | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - |
| Diabetes-related health expenditure | |
|---|---|
| Total diabetes-related health expenditure, USD million | - |
| Total diabetes-related health expenditure, ID million | - |
| Diabetes-related health expenditure per person, USD | - |
| Diabetes-related health expenditure per person, ID | - |
| Type 1 diabetes estimates in children and adolescents | |
|---|---|
| People with type 1 diabetes (all age groups) | - |
| People with type 1 diabetes (0-19 y) | - |
| Demographics | |
|---|---|
| Total adult population (20-79 y), in 1,000s | 55,174.0 |
| Population of children and adolescents (0-19 y) | - |
